Results from a study of Zyga Technology’s SImmetry® Sacroiliac (SI) Joint Fusion with decortication procedure indicate that, at 24 months, bridging bone was reported in 94% of patients with 83% categorized as solid fusion across the SI joint. Of patients with solid fusion, 88% of joints were fused within the area of decortication.
Previously-reported results demonstrated that 79% of patients had evidence of bridging bone at 12 months.
Further, the study demonstrated a 73% reduction in average pain at 24 months. No procedure- or device-related serious adverse events were reported.
This prospective, multi-site study evaluated 18 patients receiving SImmetry. Fusion was defined as solid (presence of solid continuous bridging bone across the treated joint), possible (presence of possible continuous bridging bone across the treated joint) or no fusion (no bridging bone).
Source: Zyga Technology, Inc.
Results from a study of Zyga Technology's SImmetry® Sacroiliac (SI) Joint Fusion with decortication procedure indicate that, at 24 months, bridging bone was reported in 94% of patients with 83% categorized as solid fusion across the SI joint. Of patients with solid fusion, 88% of joints were fused within the area of decortication.
...
Results from a study of Zyga Technology’s SImmetry® Sacroiliac (SI) Joint Fusion with decortication procedure indicate that, at 24 months, bridging bone was reported in 94% of patients with 83% categorized as solid fusion across the SI joint. Of patients with solid fusion, 88% of joints were fused within the area of decortication.
Previously-reported results demonstrated that 79% of patients had evidence of bridging bone at 12 months.
Further, the study demonstrated a 73% reduction in average pain at 24 months. No procedure- or device-related serious adverse events were reported.
This prospective, multi-site study evaluated 18 patients receiving SImmetry. Fusion was defined as solid (presence of solid continuous bridging bone across the treated joint), possible (presence of possible continuous bridging bone across the treated joint) or no fusion (no bridging bone).
Source: Zyga Technology, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.